Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Cash from Operations (2016 - 2025)

Historic Cash from Operations for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to -$8.6 million.

  • InspireMD's Cash from Operations fell 5145.61% to -$8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.5 million, marking a year-over-year decrease of 6847.89%. This contributed to the annual value of -$21.9 million for FY2024, which is 3353.69% down from last year.
  • InspireMD's Cash from Operations amounted to -$8.6 million in Q3 2025, which was down 5145.61% from -$8.3 million recorded in Q2 2025.
  • InspireMD's 5-year Cash from Operations high stood at -$2.5 million for Q2 2021, and its period low was -$8.8 million during Q1 2025.
  • For the 5-year period, InspireMD's Cash from Operations averaged around -$4.9 million, with its median value being -$4.2 million (2023).
  • Its Cash from Operations has fluctuated over the past 5 years, first surged by 2078.76% in 2023, then crashed by 9138.72% in 2025.
  • InspireMD's Cash from Operations (Quarter) stood at -$2.9 million in 2021, then dropped by 10.13% to -$3.2 million in 2022, then plummeted by 30.74% to -$4.2 million in 2023, then tumbled by 61.6% to -$6.8 million in 2024, then decreased by 27.9% to -$8.6 million in 2025.
  • Its last three reported values are -$8.6 million in Q3 2025, -$8.3 million for Q2 2025, and -$8.8 million during Q1 2025.